A Study of YL242 in Subjects With Advanced Solid Tumors

计划入组 424 人 · 首次发布于 2025 年 9 月 29 日

A Study to Evaluate the Drug-drug Interaction and Safety Between "BR6001-1" and "BR6001-2"

计划入组 30 人 · 首次发布于 2023 年 12 月 11 日

A Study of BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

计划入组 21 人 · 首次发布于 2024 年 6 月 21 日

ML247

ML142

ML248

Spleen-Targeted mRNA Vaccine Shows Promise Against Hepatocellular Carcinoma in Preclinical Studies

Atavistik Bio Secures FDA IND Clearance and Fast Track Designation for ATV-1601 in Hereditary Hemorrhagic Telangiectasia

Atavistik Bio Doses First Patient in Phase 1 Trial of ATV-1601 for AKT1 E17K-Mutant Solid Tumors